Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10238-025-01659-2.

Title:
Exosome-based immunotherapy in hepatocellular carcinoma | Clinical and Experimental Medicine
Description:
Hepatocellular carcinoma (HCC) is a significant global health concern and ranks as the third leading cause of cancer-associated mortality. Systemic therapy faces the emergence of resistance, which hinders the clinical benefits. Recent evidence suggests that exosomes, measuring between 30 and 150 nm in size, which impact the antitumor immune responses, making them a promising candidate for cancer immunotherapy. Owing to their unique physical and chemical characteristics, exosomes can be tailored and engineered for a range of therapeutic objectives. In the present review, we outline the immunomodulatory functions of exosomes in the tumor microenvironment (TME) of HCC, aiming to decipher the underlying mechanisms of exosomes in remodeling suppressive TME. Moreover, we provide detailed and intuitive resource for leveraging the potential of exosomes in immunotherapy, presenting valuable strategies to improve and optimize HCC treatment. Despite the huge therapeutic potential of exosomes, significant challenges persist, including the need for standardization in exosome production, optimization of cargo loading techniques, and the assurance of safety and effectiveness in clinical applications. Addressing these challenges may pave the way for exosome-based immunotherapy for HCC patients.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

pubmed, article, google, scholar, exosomes, cas, cells, cancer, hcc, central, immune, tumor, cell, exosomal, immunotherapy, pdl, carcinoma, hepatocellular, tme, exosome, httpsdoiorgs, macrophages, therapeutic, treatment, zhang, immunosuppressive, tams, wang, therapy, expression, microenvironment, mechanisms, drug, pathway, essential, resistance, role, chen, clinical, responses, potential, polarization, progression, delivery, function, liu, additionally, sci, research, leading,

Topics {✒️}

pten/akt/nf-κb/pd-l1 pathway tnf-α/nf-κb/pu1 axis pten/akt/nf-κb pathway [52] sall4/mir-146a-5p interaction release exosomal mir-23a-3p tumor-derived exosomal pd-l1 exosomal mir-200b-3p sponging hsa-mir-194-5p synergistic tumor-targeted photo-immunotherapy targeted sp1/dnmt1 axis dynamic cd73/pd-l1 pathway tumour-derived extracellular vesicles exosomal mir-21-5p facilitated exosomal pd-l1 derived article download pdf hcc-derived exosomes represents targeted klf5/galectin-3 axis exosomal pd-l1 secreted exosomal circuhrf1 derived exosomal pd-l1 inhibited exosomal pd-l1 levels mir-301b/creb1 signals exosome-mediated genetic reprogramming exosomal pd-l1 serves targeted xct-mediated ferroptosis mir-146a-5p myeloid-derived suppressor cells exosomal pd-l1 contributes atp-adenosine metabolism reprogramming employ single-cell sequencing express pd-l1 enter soluble pd-1/pd-l1 cytosolic rna-binding proteins mir-147a/arid3a axis anti-pd-l1 antibodies exosome-derived noncoding rnas exosomal mir-124 derived tam-derived exosomes enhanced hypoxia-inducible factor-1α mir-23a-3p enhanced tumor-suppressive activity regulating pd-l1 expression adenosine-a2ar signaling pathway anti-pd-1/l1 response increased pd-l1 levels multidimensional anti-tumor therapies exosomal lncrna neat1 cell-dependent immune responses small-cell lung cancer innovative exosome-based method

Questions {❓}

  • Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Exosome-based immunotherapy in hepatocellular carcinoma
         description:Hepatocellular carcinoma (HCC) is a significant global health concern and ranks as the third leading cause of cancer-associated mortality. Systemic therapy faces the emergence of resistance, which hinders the clinical benefits. Recent evidence suggests that exosomes, measuring between 30 and 150 nm in size, which impact the antitumor immune responses, making them a promising candidate for cancer immunotherapy. Owing to their unique physical and chemical characteristics, exosomes can be tailored and engineered for a range of therapeutic objectives. In the present review, we outline the immunomodulatory functions of exosomes in the tumor microenvironment (TME) of HCC, aiming to decipher the underlying mechanisms of exosomes in remodeling suppressive TME. Moreover, we provide detailed and intuitive resource for leveraging the potential of exosomes in immunotherapy, presenting valuable strategies to improve and optimize HCC treatment. Despite the huge therapeutic potential of exosomes, significant challenges persist, including the need for standardization in exosome production, optimization of cargo loading techniques, and the assurance of safety and effectiveness in clinical applications. Addressing these challenges may pave the way for exosome-based immunotherapy for HCC patients.
         datePublished:2025-04-24T00:00:00Z
         dateModified:2025-04-24T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1007/s10238-025-01659-2
         keywords:
            Exosomes
            Hepatocellular carcinoma
            Tumor microenvironment
            Immunotherapy
            Tumor vaccine
            Internal Medicine
            Hematology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-025-01659-2/MediaObjects/10238_2025_1659_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-025-01659-2/MediaObjects/10238_2025_1659_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-025-01659-2/MediaObjects/10238_2025_1659_Fig3_HTML.png
         isPartOf:
            name:Clinical and Experimental Medicine
            issn:
               1591-9528
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Hong Liu
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:GuoWei Wang
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:ZhaoYi Li
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Department of Scientific Research and Education, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:XianTu Zhang
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:WeiDong Zhang
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Department of General Surgery I, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xia Zhang
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Fang Liu
               affiliation:
                     name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou
                     address:
                        name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jing Gao
               affiliation:
                     name:Xixi Hospital of Hangzhou
                     address:
                        name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Exosome-based immunotherapy in hepatocellular carcinoma
      description:Hepatocellular carcinoma (HCC) is a significant global health concern and ranks as the third leading cause of cancer-associated mortality. Systemic therapy faces the emergence of resistance, which hinders the clinical benefits. Recent evidence suggests that exosomes, measuring between 30 and 150 nm in size, which impact the antitumor immune responses, making them a promising candidate for cancer immunotherapy. Owing to their unique physical and chemical characteristics, exosomes can be tailored and engineered for a range of therapeutic objectives. In the present review, we outline the immunomodulatory functions of exosomes in the tumor microenvironment (TME) of HCC, aiming to decipher the underlying mechanisms of exosomes in remodeling suppressive TME. Moreover, we provide detailed and intuitive resource for leveraging the potential of exosomes in immunotherapy, presenting valuable strategies to improve and optimize HCC treatment. Despite the huge therapeutic potential of exosomes, significant challenges persist, including the need for standardization in exosome production, optimization of cargo loading techniques, and the assurance of safety and effectiveness in clinical applications. Addressing these challenges may pave the way for exosome-based immunotherapy for HCC patients.
      datePublished:2025-04-24T00:00:00Z
      dateModified:2025-04-24T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1007/s10238-025-01659-2
      keywords:
         Exosomes
         Hepatocellular carcinoma
         Tumor microenvironment
         Immunotherapy
         Tumor vaccine
         Internal Medicine
         Hematology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-025-01659-2/MediaObjects/10238_2025_1659_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-025-01659-2/MediaObjects/10238_2025_1659_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-025-01659-2/MediaObjects/10238_2025_1659_Fig3_HTML.png
      isPartOf:
         name:Clinical and Experimental Medicine
         issn:
            1591-9528
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Hong Liu
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:GuoWei Wang
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:ZhaoYi Li
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Department of Scientific Research and Education, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:XianTu Zhang
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:WeiDong Zhang
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Department of General Surgery I, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xia Zhang
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Fang Liu
            affiliation:
                  name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou
                  address:
                     name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jing Gao
            affiliation:
                  name:Xixi Hospital of Hangzhou
                  address:
                     name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Clinical and Experimental Medicine
      issn:
         1591-9528
      volumeNumber:25
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Xixi Hospital of Hangzhou
      address:
         name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital of Hangzhou
      address:
         name:Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital of Hangzhou
      address:
         name:Department of Scientific Research and Education, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital of Hangzhou
      address:
         name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital of Hangzhou
      address:
         name:Department of General Surgery I, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital of Hangzhou
      address:
         name:Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou
      address:
         name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
      name:Xixi Hospital of Hangzhou
      address:
         name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Hong Liu
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:GuoWei Wang
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:ZhaoYi Li
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Department of Scientific Research and Education, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:XianTu Zhang
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:WeiDong Zhang
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Department of General Surgery I, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      name:Xia Zhang
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Fang Liu
      affiliation:
            name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou
            address:
               name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jing Gao
      affiliation:
            name:Xixi Hospital of Hangzhou
            address:
               name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Department of Scientific Research and Education, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Department of General Surgery I, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Xixi Hospital Biobank, Xixi Hospital of Hangzhou, Hangzhou, China
      name:Department of Pathology, Xixi Hospital of Hangzhou, Hangzhou, China

External Links {🔗}(655)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.81s.